Support The REAL Kenan's Law: Ban Illicit "Tranq" Precursors

1

Let’s get to 5 signatures!
Petitions with 1,000+ supporters are 5x more likely to win!

The Issue

The Mandate: Immediately invoke federal import detention authorities under Section 801(a) of the FD&C Act to seize all uncertified shipments of medetomidine and related veterinary alpha-2 agonists, designate medetomidine an official Emerging Drug Threat, and pass emergency class-based precursor scheduling under the Controlled Substances Act to halt the influx of unregulated bulk chemicals from overseas manufacturers.

1. The Chemical Crisis on American Streets
America’s synthetic drug crisis is undergoing an alarming chemical mutation. Street opioids are no longer just fentanyl—they are being co-formulated with industrial-scale veterinary tranquilizers known collectively as "Tranq."

First came xylazine, which produces necrotic cutaneous ulcers so severe that regional limb amputations have doubled. Now, an even more dangerous compound has infiltrated the supply: medetomidine ("rhino tranq")—an intensive-care veterinary anesthetic estimated by toxicologists and the DEA to be 100 to 200 times more potent than xylazine.

This is not simply an "overdose" crisis in the conventional sense:

Naloxone Resistance: Because medetomidine and xylazine are non-opioid alpha-2 adrenergic agonists, naloxone (Narcan) does not reverse their sedative coma or cardiovascular collapse.
Violent Autonomic Withdrawal & ICU Overload: When medetomidine wears off, patients suffer extreme autonomic rebound—marked by severe hypertension, heart rates exceeding 100 bpm, neurological "brain zaps," and organ strain. In hard-hit cities like Philadelphia, this acute withdrawal has occupied up to 25% of all hospital ICU beds, overwhelming emergency healthcare systems.
 
2. Tracing the Source: Overseas Clandestine Labs and Cheap Chemical Exports
Where are these drugs coming from? They are not coming from local veterinary clinics.

The $6/kg Profit Incentive: Official DEA reports reveal that bulk active pharmaceutical powders have historically been purchased online directly from unregulated chemical manufacturers in China for as little as $6 to $20 per kilogram. At these prices, transnational drug trafficking cartels purchase cheap bulk sedatives to stretch fentanyl volumes, mask its short duration, and multiply illicit profits.
Forensic Proof of Clandestine Synthesis: Federal toxicological testing published by the CDC confirms that street medetomidine consists of unpreserved racemic mixtures of levomedetomidine and dexmedetomidine. Legitimate human medicine uses exclusively purified dexmedetomidine, and veterinary formulations contain strict pharmaceutical preservatives. This forensic evidence proves that street "rhino tranq" is being synthesized in unregulated clandestine chemical laboratories overseas and mailed into the United States through international postal channels.
The "Whack-a-Mole" Regulatory Failure: When state governments banned xylazine, traffickers simply pivoted to medetomidine overnight. Because medetomidine remained unscheduled under federal law, foreign suppliers could ship it into U.S. ports of entry with minimal border scrutiny.
 
3. What We Are Demanding:
We demand that federal regulators and congressional leaders close these chemical loopholes immediately:

  1. Issue an Immediate FDA Import Alert for Medetomidine: The FDA must exercise its statutory authority under Section 801(a) of the FD&C Act [21 U.S.C. § 381(a)]—mirroring its February 2023 action against xylazine—to place medetomidine, its isomers, and its raw chemical precursors under Detention Without Physical Examination (DWPE) at all U.S. ports of entry and International Mail Facilities. No shipment should enter the country without verified proof that the recipient is an FDA-approved manufacturer, licensed pharmacy, or state-licensed veterinarian.
    2. Hold Foreign Chemical Exporters Accountable: The federal government must exert targeted diplomatic, economic, and customs pressure on foreign manufacturing hubs—specifically online chemical vendor platforms operating in China—to shut down clandestine laboratories and halt direct-to-consumer bulk exports of unscheduled alpha-2 sedatives.
    3. Pass Class-Based Precursor Scheduling Under the Controlled Substances Act: Congress must end the cycle of chemical substitution by enacting structural legislation (building on the Combating Illicit Xylazine Act) that places the entire chemical class of non-opioid alpha-2 adrenergic agonists under federal control, while maintaining clear dual-use exemptions to protect legitimate animal healthcare and veterinary access.
    4. Mandate Hospital and Coroner Toxicological Screening: Standard hospital urine drug screens and routine county coroner tests do not detect medetomidine. We demand federal funding and statutory requirements for hospitals and medical examiners to screen for emerging alpha-2 agonists, ending the data blackout that hides the true scale of this crisis.

     

    WHY YOUR SIGNATURE MATTERS NOW:
    Every delay in federal scheduling and import interdiction allows foreign chemical networks to introduce another, even more potent synthetic analogue into our communities.

    By signing this petition, you are joining frontline toxicologists, emergency nurses, and affected families to demand that federal regulators choke the chemical pipeline at our borders before the supply mutates again.

    Sign the petition today to demand an immediate FDA Import Alert and federal precursor ban.

The Decision Makers

Janet Woodcock, M.D.
FDA Director, Center for Drug Evaluation & Research
ONDCP
House Committee on Energy and Commerce & Senate Judiciary Committee

Petition Updates